Christopher J. Coughlin - 02 Aug 2022 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Reporting relationship: Director
Issuer ticker: PBH
Reported as of: 02 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Aug 2022, 17:19:25 UTC
Prior SEC filing: 05 Jul 2022
Next SEC filing: 04 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. Coughlin by William P'Pool as attorney-in-fact pursuant to power of attorney dated July 29, 2019 on file with the Commission

Key filing fact

Christopher J. Coughlin filed Form 4 for Prestige Consumer Healthcare Inc. (PBH) on 03 Aug 2022.

Key facts

This page summarizes Christopher J. Coughlin's Form 4 filing for Prestige Consumer Healthcare Inc. (PBH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Aug 2022, 17:19.

Change

Previous filing in this sequence was filed on 05 Jul 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PBH transaction

Common Stock, par value $0.01 per share

Award

Transaction value: $0
Shares: +2,495
Change %: +23%
Price: $0.000000
Shares after: 13,218
Date: 02 Aug 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person received 2,495 restricted stock units (equal to $150,000 divided by the closing stock price of $60.12on August 2, 2022) in connection with the Issuer's director compensation program. The restricted stock units vest on August 2, 2023.